QUOTE AND NEWS
FiercePharma  Jun 27  Comment 
Boehringer Ingelheim and Eli Lilly are getting to the heart of the matter in new TV work for Jardiance. The commercial uses a man-on-the-street format, with an interviewer and camera crew talking to people with diabetes about their knowledge of...
Motley Fool  Jun 27  Comment 
Find out which of these pharmaceutical stocks is the best pick right now.
Benzinga  Jun 26  Comment 
On CNBC's "Mad Money," Jim Cramer said he wouldn't sell Helmerich & Payne, Inc. (NYSE: HP) at its current price level. He wouldn't buy it either because he thinks it might trade to $48. He likes the stock in the long term. Cramer would sell...
FierceBiotech  Jun 22  Comment 
Eli Lilly has completed the expansion of its biotech facility in San Diego, California. The Big Pharma has more than doubled the size of the West Coast site and installed an automated, remote-controlled drug design and testing studio. 
Benzinga  Jun 15  Comment 
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) shares are trading lower by $12.00 (2.2 percent) at $464.84 in Thursday's session. The decline may be a delayed reaction to the company's 8-K filing released before Wednesday's open. Also on...
Motley Fool  Jun 14  Comment 
Here are a handful of things you probably haven't heard about one of the world's largest pharmaceutical companies.
MarketWatch  Jun 13  Comment 
A corporate dispute over a price-discount program for diabetes patients taking Eli Lilly & Co.’s insulin has resulted in an industry middleman’s exit from the deal — the latest sign of discord among players in a prescription-drug supply...
FierceBiotech  Jun 13  Comment 
With three positive phase 3 trials in hand, Eli Lilly heads for the FDA with migraine drug galcanezumab in pursuit of Amgen/Novartis.




Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki